Sign inJoin waitlistJoin the waitlist

Paula Silverman

Associate Professor of Medicine · Case Western Reserve University/University Hospitals Cleveland Medical Center

Credentials: · ·

History

Case Western Reserve University/University Hospitals Cleveland Medical Center
Present

Case Comprehensive Cancer Center
1984–1987
Internal Medicine
1981–1984
Case Western Reserve University School of Medicine
1977–1981

Research

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of…
Journal of Clinical Oncology · 2017 · 271 citations
Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study
JAMA · 2009 · 220 citations
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)
Journal of Clinical Oncology · 2022 · 161 citations

BO
Beth Overmoyer
9 papers
Robert Shenk
6 papers
Janice Lyons
5 papers
Joseph Sparano
4 papers
Allison King
3 papers · 1 as a resident
Amye Tevaarwerk
3 papers
Brian Skotko
3 papers
Crystal Denlinger
3 papers
Debra Friedman
3 papers
Eric Winer
3 papers
Fadi Abdul-Karim
3 papers
Gregory Broderick
3 papers

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $126.2K · Case Western Reserve University
1997–2007

Clinical trials

Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate
Principal investigator · Completed · Phase 2
Case Comprehensive Cancer Center
2015–2020
Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer
Principal investigator · Completed · Phase 2
Case Comprehensive Cancer Center
2013–2017
Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer
Principal investigator · Terminated · Phase 1
Case Comprehensive Cancer Center
2003–2005
Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer
Principal investigator · Completed · Phase 2
Paula Silverman, MD
2002–2012